Metagen Therapeutics, Inc.
PrivateLast Round
Series B
Feb 25, 2026
Total Funding Raised
$51.71M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Metagen Therapeutics, Inc. is a biotechnology company that advances medicine and drug discovery based on human gut microbiome research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metagen Therapeutics, Inc. Comparables
Compare Metagen Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnteroBiotix | 81% | |
| BiomeBank | 81% | |
| MRM Health | 80% | |
Metagen Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 25, 2026 | ||||
| Series B | Sep 8, 2025 | ||||
| Series A | Jun 15, 2023 | ||||
| Pre Seed | Jun 30, 2022 | ||||
| Seed | Mar 17, 2021 |
Key People
Founding team and executive leadership
Metagen Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Seed, Series A, Pre Seed, Series B |
| Sparx Asset Management | Series A, Series B |
| Tokai Tokyo Investment Co., Ltd. | Series B |
| Keio Innovation Initiative | Seed, Series A, Pre Seed, Series B |
| Mizuho Capital | Series A, Series B |
| Arcus Investment | Series B |
| 日本ベンチャーキャピタル株式会社 | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2025
Company is in the N-2 stage, indicating a potential listing in approximately two years.
- Nov 10, 2025
Partnering with Juntendo University for ulcerative colitis research.
Metagen Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Metagen Therapeutics, Inc.'s valuation, stock price, and market status.